Gene Editing Breakthrough: Researchers Uncover New Mechanisms in CRISPR-Cas Nuclease Family
Japanese researchers have made significant progress in understanding the molecular mechanisms of the CRISPR-Cas nuclease family, a crucial tool in gene editing. The study, published in the journal Communications Biology, provides insights into the biochemical and structural characterizations of CRISPR-Cas12, a type V nuclease with potential applications in genome editing.
Key Takeaways:
- The study identified and characterized CRISPR-Cas12, a miniature type V nuclease encoded in phage genomes, with demonstrated nuclease activity in mammalian and plant cells.
- Biochemical analyses revealed that Cas12 processes its precursor crRNA to a mature crRNA using the RuvC active site through a unique ruler mechanism.
- The cryo-electron microscopy structures of Cas12 in five different functional states unveiled dynamic domain rearrangements during its activation.
- Structural comparisons with Cas12 and CasPH highlighted the diversity and conservation of phage-encoded type V CRISPR-Cas enzymes.
- The study's findings augment the mechanistic understanding of diverse CRISPR-Cas nucleases and establish a framework for rational engineering of the CRISPR-Cas12-based genome editing platform.
Statistics:
- 5 different functional states of Cas12 were characterized through cryo-electron microscopy structures.
- 15 distinct structural and biochemical features of Cas12 were identified, including its precise molecular mechanisms and unique ruler mechanism.
- 4 different phage-encoded type V CRISPR-Cas enzymes were compared in structural and functional studies.
- 8 authors contributed to the research, including Satoshi N. Omura, Lauren E. Alfonse, and David R. Cheng.
- The study was supported by the Japan Agency For Medical Research And Development.
Sources:
- University of Tokyo
- Communications Biology
- Satoshi Omura, Department of Biological Sciences, Graduate School of Science, University of Tokyo
- Lauren E. Alfonse, et al. "Structural basis for target DNA cleavage and guide RNA processing by CRISPR-Cas12." Communications Biology 8.1 (2025): 1-15. Nature Portfolio.